EGFL7 and metastatic colorectal cancer: In contrast, our data suggest that EGFL7 expression in tumor parenchyma is not associated with differences in overall survival and, additionally, low expression is associated with increased lymph node spread and invasion of lymphatic vessels of metastatic colorectal cancer.